Intera Atlas
Run match
Sites / Artemis Institute for Clinical Research
Is this you?

Request access for Artemis Institute for Clinical Research with your @artemis-research.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Artemis Institute for Clinical Research

Unclaimed profile

Hybrid / Network (Headlands Research affiliate) · Atlantis, FL (corporate); Riverside CA, San Diego CA, Orlando FL sites · ~3 (min; Riverside, San Diego, Atlantis/Orlando area) sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 6Lift (cardio sample) 0.44Recruit soph 0.43
Quality Scorecard (1–100)
Overall72Recruit72Ops75Sponsor72Ther68

Performance (observed)

Historical trials
261
Completed
176
Terminated/Withdrawn
29
Completion rate
86%
Active now
54
Phase 2
99
Phase 3
153
Realized enrollment
461,190
First study year
2007
Years active
19
Match confidence
high
Enrollment velocity (inf)
24,273

Therapeutic

Areas
Broad (12+ therapeutic areas): cardiovascular, psychiatric, pain, sleep, endocrinology, dermatology, etc.
Specialties
Psychiatry, Neurology, Vaccine, Inpatient, Medical Devices; 12 therapeutic areas
Breadth (conditions)
160
Languages
English/Spanish (Headlands bilingual)
States
CA, FL (multi-state)

Recruitment (web observed)

Trial Finder
Yes
Patient database
Headlands network access
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Moderate (Headlands branding)
Capability notes
Active multi-site enrollment; 'ENROLLING NOW' status on multiple studies; dedicated patient recruitment phone line (1-855-DoStudies); participant-centered approach

Relationships

Sponsors
Eli Lilly and Company; Pfizer; Merck Sharp & Dohme LLC; Sumitomo Pharma America, Inc.; Janssen Research & Development, LLC; ModernaTX, Inc.
CROs
Medpace, Inc.; PPD Development, LP; Premier Research; Syneos Health
Partnerships
Headlands Research (parent company)
Owner / parent
Part of Headlands Research (founded 2018, 135 employees, $14.5M revenue, $29.2M total funding)
Funding
PE: KKR-backed Headlands Research
Acquisitions
Acquired by Headlands Research (Feb 2021)
Expansion
Part of Headlands 13-site global network

Capacity & people

Investigators
—
Coordinators
—
CEO
Kyle Burtnett (Headlands Research CEO, parent org)
VP Clinical Ops
Unknown (Headlands level)
VP Site Ops
Unknown (Headlands level)
VP Recruitment
Lauren Chazal, Chief Business Development Officer (Headlands)
Emails
recruitment@artemis-research.com

Tech & DCT

eSource
Yes
eConsent
Yes
Builds tech
Vendors (Headlands Research parent company infrastructure)
DCT / decentralized
N
Tech stack
Unknown (no specific CTMS or AI mentioned; Headlands-backed infrastructure)
Recruiting visible
Y

Notes

Multi-site Headlands Research affiliate (3+ locations: Riverside, San Diego, Atlantis/Orlando). Broad therapeutic mix (12+ areas). Active patient recruitment channels. Part of larger $29.2M-funded Headlands network (5,000+ trials completed). Participant-centered approach. Lacks visible tech differentiation (AI, CTMS not mentioned). Moderate scale for Artemis brand alone but backed by growing Headlands parent. Fair Intera fit given multi-site structure and broad therapeutic reach, but parent org (Headlands) may provide direct partnership opportunity at enterprise level. [Validated: 5 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 0.78Liftability 0.44Overall72

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.